 |
answer text |
<p>Building on the 100,000 Genomes Project and existing genetic services, NHS England
announced in October 2018 that over the next 18 months, work to mobilise the NHS Genomic
Medicine Service (GMS) would get underway, providing consistent and equitable care
for the country’s 55 million population.</p><p>Investment for genomics was included
as part of the NHS Long Term Plan, setting out commitments over the next five years
to:</p><p>- Sequence 500,000 whole genomes by 2023/24, as part of a Government commitment
to sequence 1 million whole genomes;</p><p>- Extend the use of molecular diagnostic
testing and routine offering whole genome sequencing to seriously ill children who
are likely to have a rare genetic disorder, children with cancer, and adults suffering
from certain rare conditions or specific cancers;</p><p>- Link and correlate genomics,
clinical data and data from patients, providing routes to new treatments, diagnostic
patterns and information to help patients make informed decisions about their care;
and</p><p>- Increase the number of people identified with familial hypercholesterolaemia
(inherited high cholesterol) from 7% to 25% over the next five years.</p><p>The NHS
Genomic Medicine Service will be supported by an informatics system that is being
developed in partnership with Genomics England. When fully operational, the informatics
system will enable NHS England to monitor the number of genomic tests being carried
out across the country and benchmark activity.</p>
|
|
